Skip to main content
. Author manuscript; available in PMC: 2021 Feb 16.
Published in final edited form as: Nucl Med Biol. 2020 Sep 15;90-91:31–40. doi: 10.1016/j.nucmedbio.2020.09.002

Fig. 4. WBC radiolabelling with [89Zr]Zr-oxine and [111In]In-oxine.

Fig. 4

(a) WBC labelling efficiency with [89Zr]Zr-oxine and [111In]In-oxine. Mean ± SD of n = 10 per group. ****P < 0.0001 (Student’s two-tailed paired t-test). (b) Retention of89Zrand 111In in WBC, 4 h and 24 h after radiolabelling. n = 10 per group, P > 0.05 (Wilcoxon’s matched pair signed-rank test). (c) Viability of 89Zr- and 111In-labelled WBC after 4 h and 24 h. Mean ± SD of n = 6 per group, Student’s two-tailed paired t-test.